Search

Your search keyword '"Takahashi, Masanori"' showing total 1,235 results

Search Constraints

Start Over You searched for: Author "Takahashi, Masanori" Remove constraint Author: "Takahashi, Masanori"
1,235 results on '"Takahashi, Masanori"'

Search Results

1. Enhancing evidence-informed policymaking in medicine and healthcare: stakeholder involvement in the Commons Project for rare diseases in Japan

3. Switching disease-modifying therapies from sphingosine-1-phosphate receptor modulators to natalizumab or dimethyl fumarate restores immune responses after SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis

4. Worsening of myasthenic symptoms associated with statins

5. Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis

7. Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in Japan

8. Taste disorders and alopecia in myasthenia gravis

9. Safety and efficacy of aceneuramic acid in GNE myopathy: open-label extension study

10. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

11. Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

20. Lineage tracing using Wnt2b‐2A‐CreERT2 knock‐in mice reveals the contributions of Wnt2b‐expressing cells to novel subpopulations of mesothelial/epicardial cell lineages during mouse development.

26. A web-based questionnaire survey on the influence of coronavirus disease-19 on the care of patients with muscular dystrophy

27. Erythromycin for myotonic dystrophy type 1: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

29. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

32. Real‐world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis.

34. The practice of active patient involvement in rare disease research using ICT: experiences and lessons from the RUDY JAPAN project

36. RGMa collapses the neuronal actin barrier against disease-implicated protein and exacerbates ALS

40. Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

44. Rigorous evaluation of genetic and epigenetic effects on clinical laboratory measurements using Japanese monozygotic twins.

45. Phase II/III Study of Aceneuramic Acid Administration for GNE Myopathy in Japan

47. Cardiac Emerinopathy: A Non-syndromic Nuclear Envelopathy with Increased Risk of Thromboembolic Stroke due to Progressive Atrial Standstill and Left Ventricular Non-compaction

50. Downstream genes of Pax6 revealed by comprehensive transcriptome profiling in the developing rat hindbrain

Catalog

Books, media, physical & digital resources